Saturday, April 04, 2020 11:59:45 AM
Early and sufficiently large doses of intravenous vitamin C are critical. Vitamin C is not only a prototypical antioxidant, but also involved in virus killing and prevention of viral replication. The significance of large dose intravenous vitamin C is not just at antiviral level. It is acute respiratory distress syndrome (ARDS) that kills most people from coronaviral pandemics (SARS, MERS and now NCP). ARDS is a common final pathway leading to death.
Doses of 4,000-16,000 milligrams were utilized in many patients often times being effective in the first day of treatment. Intravenous is primarily for bioavailability. Taking that much Vit C orally could cause some major gastrointestinal distress.
NAC has also been shown to aid greatly in lung debris removal.
Personal recommendation: Vit D, Extra Zinc, Vit C, NAC, Elderberry (if no pre existing autoimmune issues), curcumin, ginger.
Doses of 4,000-16,000 milligrams were utilized in many patients often times being effective in the first day of treatment. Intravenous is primarily for bioavailability. Taking that much Vit C orally could cause some major gastrointestinal distress.
NAC has also been shown to aid greatly in lung debris removal.
Personal recommendation: Vit D, Extra Zinc, Vit C, NAC, Elderberry (if no pre existing autoimmune issues), curcumin, ginger.
Recent SPY News
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 02/26/2026 09:49:39 PM
- Form 497 - Definitive materials • Edgar (US Regulatory) • 01/26/2026 10:07:02 PM
- Form 485BPOS - Post-effective amendment [Rule 485(b)] • Edgar (US Regulatory) • 01/26/2026 07:06:17 PM
- Form 24F-2NT - Rule 24f-2 notice • Edgar (US Regulatory) • 12/17/2025 04:38:46 PM
- Form N-30D - Annual and semi-annual reports mailed to shareholders [Rule 30d-1] • Edgar (US Regulatory) • 11/25/2025 10:03:00 PM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 08/28/2025 04:03:24 PM
- Form N-30D - Annual and semi-annual reports mailed to shareholders [Rule 30d-1] • Edgar (US Regulatory) • 05/29/2025 07:49:30 PM
